Meetings - The ASCO Post

This is Part 3 of The Evolving Targeted Treatment Landscape for Colorectal Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable. In this video, Dr...

colorectal cancer

genomics/genetics

/ The Evolving Treatment Landscape for Colorectal Cancer

BRAF V600E–Mutated Colon Cancer

This is Part 2 of The Evolving Targeted Treatment Landscape for Colorectal Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable. In this video, Dr...

colorectal cancer

/ The Evolving Treatment Landscape for Colorectal Cancer

HER2-Positive Metastatic Colorectal Cancer

This is Part 1 of The Evolving Targeted Treatment Landscape for Colorectal Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable. In this video, Dr...

The Evolving Treatment Landscape for Colorectal Cancer

First-Line Therapy of Metastatic Colon Cancer

BRAF V600E–Mutated Colon Cancer

HER2-Positive Metastatic Colorectal Cancer

Combination of Two Oral Agents May Improve Progression Free Survival in Patients With Previously Untreated CLL

Primary Analysis of ZUMA-2: Treatment of BTK Inhibitor–Naive Relapsed/Refractory Mantle Cell Lymphoma

Primary Analysis of ZUMA-2 Treatment of BTK Inhibitor-Naive Relapsed Refractory Mantle Cell Lymphoma

FDA Grants Accelerated Approval to Encorafenib Combination for BRAF V600E–Mutant Metastatic Colorectal Cancer

SEQUOIA 5-Year Follow-up Zanubrutinib vs Bendamustine/Rituximab in Treatment-Naive CLL/SLL